Information Library

Results for: Clinical Services - Market Access

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Cancer Treatments and the Search for Value

    White Paper — April 2, 2012
    Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer

  • Quintiles Forms New Biomarker Research and Development Company

    Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

  • How Informative is Your Segmentation?

    Hear from the Experts — September 15, 2011
    Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011.

  • Shifting Sands

    Media Coverage — September 2, 2011
    As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa.

  • Malaria Prevention in Sub-Saharan Africa

    Case Study — June 24, 2011
    This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands

  • Advancing Vaccine Development in Australia and New Zealand

    Case Study — April 11, 2011
    Quintiles rose to the challenge of a very aggressive vaccine recruitment timeline during the holiday period - and recruited 3,000+ subjects from 18-90 years of age within just 17 days - 25 days ahead of schedule.

  • Leveraging social networks to conduct observational research

    Presentation — March 26, 2011
    Quintiles’ presentation describes the benefits of social networks in terms of patient identification, cost and time, relative to traditional observational research approaches.

  • The Use of Large Simple Trials

    Presentation — February 25, 2011
    Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data.

  • Oncology Drug Development and Value-Based Medicine

    White Paper — November 5, 2010
    This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices.

  • The Art and Science of Segmentation

    Presentation — October 9, 2010
    Quintiles presentation delivers fresh insights into the art and science of segmentation and its practical applications in market research. The presentation features a key Pfizer case study.

Page 1 of 2 (17 results)

Subscribe to Email Based on Your Interests

Set preferences